CoChat

The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis

Open access
Lazarevic, Dragana, Pistorio, Angela, Palmisani, Elena, Miettunen, Paivi, Ravelli, Angelo, Pilkington, Clarissa, Wulffraat, Nico M, Malattia, Clara, Garay, Stella Maris, Hofer, Michael, Quartier, Pierre, Dolezalova, Pavla, Penades, Inmaculada Calvo, Ferriani, Virginia P L, Ganser, Gerd, Kasapcopur, Ozgur, Melo-Gomes, Jose Antonio, Reed, Ann M, Wierzbowska, Malgorzata, Rider, Lisa G, Martini, Alberto, Ruperto, Nicolino · 2013 · Annals of the Rheumatic Diseases
Cited by 168

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Objectives To develop data-driven criteria for clinically inactive disease on and off therapy for juvenile dermatomyositis (JDM). Methods The Paediatric Rheumatology International Trials Organisation (PRINTO) database contains 275 patients with active JDM evaluated prospectively up to 24 months. Thirty-eight patients off therapy at 24 months were defined as clinically inactive and included in the reference group. These were compared with a random sample of 76 patients who had active disease at study baseline. Individual measures of muscle strength/endurance, muscle enzymes, physician's and parent's global disease activity/damage evaluations, inactive disease criteria derived from the literature and other ad hoc criteria were evaluated for sensitivity, specificity and Cohen's κ agreement. Results The individual measures that best characterised inactive disease (sensitivity and specificity >0.8 and Cohen's κ >0.8) were manual muscle testing (MMT) ≥78, physician global assessment of muscle activity=0, physician global assessment of overall disease activity (PhyGloVAS) ≤0.2, Childhood Myositis Assessment Scale (CMAS) ≥48, Disease Activity Score ≤3 and Myositis Disease Activity Assessment Visual Analogue Scale ≤0.2. The best combination of variables to classify a patient as being in a state of inactive disease on or off therapy is at least three of four of the following criteria: creatine kinase ≤150, CMAS ≥48, MMT ≥78 and PhyGloVAS ≤0.2. After 24 months, 30/31 patients (96.8%) were inactive off therapy and 69/145 (47.6%) were inactive on therapy. Conclusion PRINTO established data-driven criteria with clearly evidence-based cut-off values to identify JDM patients with clinically inactive disease. These criteria can be used in clinical trials, in research and in clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2012-201483

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 168

Metadata

Authors
Lazarevic, D., Pistorio, A., Palmisani, E., Miettunen, P., Ravelli, A., Pilkington, C., Wulffraat, N. M., Malattia, C., Garay, S. M., Hofer, M., Quartier, P., Dolezalova, P., Penades, I. C., Ferriani, V. P. L., Ganser, G., Kasapcopur, O., Melo-Gomes, J. A., Reed, A. M., Wierzbowska, M., Rider, L. G., Martini, A., & Ruperto, N.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2013-05
Volume
72
Issue
5
Pages
686-693
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2169977205
Cited by
168
References
2
FWCI
6.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. https://app.cochat.ai/papers/10.1136/annrheumdis-2012-201483
The paper
Lazarevic, D., Pistorio, A., Palmisani, E., Miettunen, P., Ravelli, A., Pilkington, C., Wulffraat, N. M., Malattia, C., Garay, S. M., Hofer, M., Quartier, P., Dolezalova, P., Penades, I. C., Ferriani, V. P. L., Ganser, G., Kasapcopur, O., Melo-Gomes, J. A., Reed, A. M., Wierzbowska, M., . . . Ruperto, N. (2013). The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-201483

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.